Dealing with the combinatorial complexity of protein engineering: bi- and multi-specifics, TCRs and CAR Ts

• New technology platform that fully automates molecular design, as well as the integrated assessment of potency, efficacy, and developability profiling of large panels of bispecific candidates
• Use cases showing the systematic cloning, expression, purification, and characterization of complex multi-specific, CAR T and TCR modalities, with a focus on immuno-oncology applications

Jessy Sheng, Ph.D., Scientific Consultant, Genedata